跳至主要内容
临床试验/NCT06037902
NCT06037902招募中不适用

Use of CPAP (Continuous Positive Airway Pressure) for Simulating Esophageal Cancer Patients Prior to Radiotherapy

Sheba Medical Center2 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2023年8月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
44
试验地点
2
主要终点
absolute mean heart radiation dose

研究概览

简要总结

The goal of this clinical trial is to test the use of CPAP in patients with esophgaeal cancer undergoing radiotherapy.

The main questions it aims to answer are:

  • does use of CPAP decrease exposure of normal lung to radiation?
  • does use of CPAP decrease exposure of normal heart to radiation?

Participants will undergo simulation twice:

  • with CPAP
  • without CPAP

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of cancer, with a tumor (primary or secondary) in the esophagus including tumors in the esophagus-stomach junction.
  • Planned RT treatment
  • The level of functioning ≥ 60 on the Karnofsky scale
  • Life expectancy ≥ two months
  • All patients must understand the informed consent form document and sign it of their own free will before any test/procedure related to the study is performed.
  • Able to undergo simulation and radiation with CPAP
  • Candidate patients can be recruited to receive definitive, palliative or pre-operative radiation, with or without chemotherapy.

排除标准

  • A person who meets any of the following exclusion criteria will not be able to participate in the study:
  • Pregnancy or breastfeeding
  • Significant comorbidity at the starting point that would prevent the use of CPAP
  • Hospitalized in an institution by virtue of an administrative order or a court order.
  • Special population
  • A history of a psychiatric problem that may impair the patient's ability to understand the research requirements or respond to them, or to give his consent

结局指标

主要结局

absolute mean heart radiation dose

时间窗: on day of simulation (day 1)

measured in Gy

次要结局

  • heart dose in Gy(on day of simulation (day 1))
  • lung dose in Gy(on day of simulation (day 1))
  • movement of tumor in cm(on day of simulation (day 1))

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr. Yaacov Lawrence

Chair of Department of Radiation Oncology, principal investigator

Sheba Medical Center

研究点 (2)

Loading locations...

相似试验